{"canonical":"https://abierto.us/vendors/cmc-pharmaceuticals-inc-r9avs7xl2yb4","key":"R9AVS7XL2YB4","name":"CMC PHARMACEUTICALS, INC.","uei":"R9AVS7XL2YB4","city":"SOLON","state":"OH","awards":1,"obligated":"431622.00","notices_won":0,"top_agency_name":"Department of the Army","top_naics":"541715","cage":"7UJR5","parent_name":"CMC PHARMACEUTICALS, INC.","also_known_as":[],"country":"USA","actions":1,"first_action":"2024-05-15","last_action":"2024-05-15","breakdowns":{"naics":[{"key":"541715","name":null,"awards":1,"obligated":"431622.00"}],"places":[{"key":"OH","name":null,"awards":1,"obligated":"431622.00"}],"agencies":[{"key":"2100","name":"Department of the Army","awards":1,"obligated":"431622.00"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"431622.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"431622.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":1,"obligated":"431622.00"}],"product_service_codes":[{"key":"AC12","name":null,"awards":1,"obligated":"431622.00"}]},"awards_list":[{"award_key":"CONT_AWD_W911SR23C0019_9700_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_W911SR23C0019_9700_-NONE-_-NONE-/","piid":"W911SR23C0019","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"R9AVS7XL2YB4","recipient_name":"CMC PHARMACEUTICALS, INC.","recipient_uei":"R9AVS7XL2YB4","recipient_cage":"7UJR5","recipient_city":"SOLON","recipient_state":"OH","sub_name":"Department of the Army","office_name":"W6QK ACC-APG","office_key":"o-W911SR","first_action_date":"2024-05-15","last_action_date":"2024-05-15","actions":1,"obligated":"431622.00","current_total_value":"1094180.64","potential_total_value":"1094180.64","naics":"541715","psc":"AC12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":1,"description":"MODIFICATION P00002 EXERCISES OPTIONAL CONTRACT LINE ITEM 0002 FOR CONTINUED RESEARCH OF PHARMACEUTICAL DEVELOPMENT, PLANNING, AND CMO IDENTIFICATION FOR THE EXPEDITED ADVANCEMENT OF A SCOPOLAMINE MULTI-DOSE-VIAL DRUG PRODUCT.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}